State

New Mexico product recalls

73,738 recalls have nationwide distribution and so reach New Mexico. 3,636 additional recalls listed New Mexico specifically in their distribution scope.

What the numbers show

Total: 3,636
Critical: 745
Severe: 815
Most recent: 2026-10-28

Of the 3,636 recalls naming New Mexico we have scored against our rubric, 745 (20%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 815 (22%) are Severe.

Which agencies issued them

These figures cover only the 3,636 recalls whose distribution notice names New Mexico specifically. The 73,738 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

30976–31000 of 77374

SevereFDA (Drugs)·D-0949-2020·2020-03-11
Axia Pharmaceutical Recalls Cyanocobalamin/Folinic Acid Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Cyanocobalamin/Folinic Acid Injection because the product lacks assurance of sterility.
Product
Cyanocobalamin/Folinic Acid Injection, CYANOCOBALAMIN : FOLINIC ACID 2000 MCG/ML: 500MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0333-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-1362-2020·2020-03-11
CareFusion Alaris PCA Module Recalled for Software Errors
CareFusion 303, Inc. is recalling CareFusion Alaris PCA Module, Model 8120 units due to software errors that may cause infusion interruptions or incorrect medication concentrations.
Product
CareFusion Alaris PCA Module, Model 8120
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0938-2020·2020-03-11
Axia Pharmaceutical Recalls Alprostadil Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Alprostadil/Papaverine/Phentolamine Injection due to a lack of assurance of sterility. The product was distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection 40MCG/30MG/2MG/ML Injectable, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0546-2
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0977-2020·2020-03-11
Axia Pharmaceutical Recalls Nicotinamide Adenine Dinucleotide Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Nicotinamide Adenine Dinucleotide (PF) Injection because the FDA determined there is a lack of assurance of sterility.
Product
Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 50 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0306-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Devices)·Z-1360-2020·2020-03-11
CareFusion Alaris Pump Module Recalled for Software Errors
CareFusion 303, Inc. is recalling Alaris Pump Module Model 8100 units due to software errors that may cause infusion interruptions or incorrect medication concentrations.
Product
CareFusion Alaris Pump Module, Model 8100
Category
Medical Device
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0947-2020·2020-03-11
Axia Pharmaceutical Recalls Coenzyme Q10 Injection Due to Sterility Concerns
Fusion IV Pharmaceuticals is recalling Coenzyme Q10 Injection due to a lack of assurance of sterility. The product was distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Coenzyme Q10 Injection,COENZYME Q-10 20MG/ML OIL INJ SOLN, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0411-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0960-2020·2020-03-11
Axia Pharmaceutical Recalls Polidocanol Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Polidocanol Injection because the company cannot guarantee the product is sterile.
Product
Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-060-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0965-2020·2020-03-11
Axia Pharmaceutical Recalls Methionine Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Methionine/Inositol/Choline Injection due to a lack of assurance of sterility. The affected product is distributed in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Methionine/Inositol/Choline Injection, METHIONINE/INOSITOL/CHOLINE 25MG/50MG/50MG/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0215-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0961-2020·2020-03-11
Axia Pharmaceutical Recalls Levocarnitine Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Levocarnitine Injection because the company cannot guarantee the product's sterility.
Product
Levocarnitine Injection, LEVOCARNITINE 500 MG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-9260-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0994-2020·2020-03-11
Axia Pharmaceutical Recalls Zinc Chloride Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Zinc Chloride Injection because the product lacks assurance of sterility.
Product
Zinc Chloride Injection, ZINC CHLORIDE 10MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0224-3
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0971-2020·2020-03-11
Axia Pharmaceutical Recalls Methylprednisolone Acetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Methylprednisolone Acetate Injectable Suspension because the product lacks assurance of sterility.
Product
Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0958-2020·2020-03-11
Axia Pharmaceutical Recalls Hydroxyprogesterone Caproate Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Hydroxyprogesterone Caproate Injection because the product lacks assurance of sterility. The recall covers specific lots distributed nationwide and in Puerto Rico, Barbados, and the Dominican Republic.
Product
Hydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 4 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0532-5
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0972-2020·2020-03-11
Axia Pharmaceutical Recalls Methylprednisolone Acetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Methylprednisolone Acetate Injectable Suspension because the company cannot guarantee the product is sterile.
Product
Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0989-2020·2020-03-11
Axia Pharmaceutical Recalls Triamcinolone Diacetate Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Triamcinolone Diacetate Injectable Suspension because the product lacks assurance of sterility.
Product
Triamcinolone Diacetate Injectable Suspension, TRIAMCINOLONE Diacetate [10ML] CMC 10MG/ML INJ SUSP, For IM, IA Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0625-1
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0932-2020·2020-03-11
Axia Pharmaceutical Recalls Alprostadil Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling Alprostadil/Papaverine/Phentolamine/Atropine Injection due to a lack of assurance of sterility. The product was distributed nationwide and in Puerto Rico, Barbados, and the Dominican Republic.
Product
Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate/Atropine Sulfate Injection, 18 mcg/1.8mg/0.2mg/0.02mg/mL, For Intracavernosal Use, Freeze, 2.5 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0547-2
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0944-2020·2020-03-11
Axia Pharmaceutical Recalls Betamethasone Injectable Suspension Due to Sterility Concerns
Axia Pharmaceutical is recalling Betamethasone Acetate/Betamethasone Injectable Suspension due to a lack of assurance of sterility. The product was distributed nationwide and in several territories.
Product
BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [5ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well. 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC…
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1446-2020·2020-03-11
Recall of Covidien Force TriVerse Electrosurgical Devices Due to Packaging Risk
The FDA is recalling 70,361 units of Covidien Force TriVerse Electrosurgical Devices because sterile packaging may be compromised, increasing the risk of infection.
Product
Covidien Force TriVerse Electrosurgical Devices, Product numbers FT3000 and FT3000DB, UDI 10884524000084 20884524000081; 10884524001937 20884524001934
Category
Medical Device
Distribution
Distributed nationwide
HighNHTSA·20V140000·2020-03-11
Heartland Recalls 2020 Shadow Cruiser Ultra Lite Trailers Due to Label Error
Heartland is recalling 2020 Shadow Cruiser Ultra Lite trailers because certification labels list incorrect GVWR and axle ratings, which could lead to overloading and axle failure.
Product
CRUISER RV — CRUISER RV SHADOW CRUISER ULTRA LITE
Category
Vehicle
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1425-2020·2020-03-11
Beckman Coulter Recalls Direct Bilirubin Reagents Due to Interference Risk
Beckman Coulter is recalling Direct Bilirubin Reagents because acetaminophen metabolites may interfere with test results, potentially delaying diagnosis and treatment.
Product
Direct Bilirubin Reagents (DBIL 2 x 200 ) and (DBIL 2 x 300), Ref:439715 (200 tests/cartridge) and 476856 (300 tests/cartridge), For In Vitro Diagnostic Use, Rx Only, UDI: 15099590575120(200 tests/cartridge) and 15099590625603(300 tests/cartridge)
Category
Medical Device
Distribution
48 states
HighFDA (Drugs)·D-0967-2020·2020-03-11
Axia Pharmaceutical Recalls Methylcobalamin Injection Due to Sterility Concerns
Axia Pharmaceutical is recalling specific lots of Methylcobalamin Injection because the product lacks assurance of sterility. The recall covers distribution in the U.S., Puerto Rico, Barbados, and the Dominican Republic.
Product
Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1422-2020·2020-03-11
Beckman Coulter Enzymatic Creatinine Reagent Recalled for Potential Diagnostic Interference
Beckman Coulter is recalling Enzymatic Creatinine Reagents because high levels of acetaminophen metabolites may interfere with test results, potentially delaying diagnosis.
Product
Enzymatic Creatinine Reagent (CR-E 2 X 200), REF A60298, For in Vitro Diagnostic Use, Rx Only, UDI: 15099590625733
Category
Medical Device
Distribution
48 states
HighFDA (Devices)·Z-1423-2020·2020-03-11
Beckman Coulter Recalls Triglycerides Reagent Due to Acetaminophen Interference
Beckman Coulter is recalling Triglycerides Reagent because high levels of acetaminophen metabolites may cause negative interference, potentially delaying diagnosis and treatment.
Product
Triglycerides Reagent (TG 2 x 300), REF: 445850, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233228
Category
Medical Device
Distribution
48 states
HighFDA (Devices)·Z-1445-2020·2020-03-11
Stryker Connected OR Cart Recalled Due to Monitor Attachment Defect
Stryker is recalling 12 Connected OR Carts because the monitor may not attach correctly, posing a risk of the monitor falling and injuring users.
Product
Stryker Connected OR Cart,120 V Ref Cat. #240-099-155, Qty 1, Rx Only, Manufactured for: Stryker, 5900 Optical Court, San Jose, CA 95138, UDI: 07613327462784 - Product Usage: The Connect OR Cart is a mobile, medical-grade cart intended to store and transport components of…
Category
Medical Device
Distribution
Distributed nationwide
HighNHTSA·20V141000·2020-03-11
Turtle Top Odyssey Recall for Seatbelt Warning Light Defect
Turtle Top is recalling 2019 Odyssey vehicles because the seatbelt-unfastened warning light may not illuminate for five seconds after ignition, increasing crash injury risk.
Product
TURTLE TOP — TURTLE TOP ODYSSEY
Category
Vehicle
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0986-2020·2020-03-11
Recall of Triamcinolone Acetonide/Bupivacaine Injectable Suspension Due to Sterility Concerns
FDA recalls Triamcinolone Acetonide/Bupivacaine Injectable Suspension due to lack of sterility assurance. The drug was distributed nationwide and in Puerto Rico, Barbados, and the Dominican Republic.
Product
Triamcinolone Acetonide/Bupivacaine Hydrochloride Injectable Suspension, TRIAMCINOLONE ACET/BUPIVACAINE HCL [10ML] 40MG/5MG/ML INJ SUSP, For IM, IA Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0632-1
Category
Drug
Distribution
Distributed nationwide